首页> 外文期刊>The Tohoku Journal of Experimental Medicine >Modified Cut-Off Value of the Urine Protein-To-Creatinine Ratio Is Helpful for Identifying Patients at High Risk for Chronic Kidney Disease: Validation of the Revised Japanese Guideline
【24h】

Modified Cut-Off Value of the Urine Protein-To-Creatinine Ratio Is Helpful for Identifying Patients at High Risk for Chronic Kidney Disease: Validation of the Revised Japanese Guideline

机译:尿蛋白与肌酐比值的修正临界值有助于识别患有慢性肾脏病高风险的患者:修订的日本指南的验证

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic kidney disease (CKD) is a global public health issue, and strategies for its early detection and intervention are imperative. The latest Japanese CKD guideline recommends that patients without diabetes should be classified using the urine protein-to-creatinine ratio (PCR) instead of the urine albumin-to-creatinine ratio (ACR); however, no validation studies are available. This study aimed to validate the PCR-based CKD risk classification compared with the ACR-based classification and to explore more accurate classification methods. We analyzed two previously reported datasets that included diabetic and/or cardiovascular patients who were classified into early CKD stages. In total, 860 patients (131 diabetic patients and 729 cardiovascular patients, including 193 diabetic patients) were enrolled. We assessed the CKD risk classification of each patient according to the estimated glomerular filtration rate and the ACR-based or PCR-based classification. The use of the cut-off value recommended in the current guideline (PCR 0.15 g/g creatinine) resulted in risk misclassification rates of 26.0% and 16.6% for the two datasets. The misclassification was primarily caused by underestimation. Moderate to substantial agreement between each classification was achieved: Cohen's kappa, 0.56 (95% confidence interval, 0.45-0.69) and 0.72 (0.67-0.76) in each dataset, respectively. To improve the accuracy, we tested various candidate PCR cut-off values, showing that a PCR cut-off value of 0.08-0.10 g/g creatinine resulted in improvement in the misclassification rates and kappa values. Modification of the PCR cut-off value would improve its efficacy to identify high-risk populations who will benefit from early intervention.
机译:慢性肾脏病(CKD)是一个全球性的公共卫生问题,必须尽早发现和干预其策略。日本最新的CKD指南建议,应使用尿蛋白与肌酐之比(PCR)代替尿白蛋白与肌酐之比(ACR)对非糖尿病患者进行分类;但是,没有可用的验证研究。这项研究旨在验证与基于ACR的分类相比,基于PCR的CKD风险分类,并探索更准确的分类方法。我们分析了两个先前报道的数据集,其中包括归类为CKD早期阶段的糖尿病和/或心血管患者。总共招募了860位患者(131位糖尿病患者和729位心血管患者,包括193位糖尿病患者)。我们根据估计的肾小球滤过率和基于ACR或基于PCR的分类评估了每个患者的CKD风险分类。使用当前指南中建议的临界值(PCR 0.15 g / g肌酐)导致两个数据集的风险错误分类率分别为26.0%和16.6%。分类错误主要是由于低估造成的。每种分类之间均达到了中度到实质性的一致性:每个数据集中的Cohenκ分别为0.56(95%置信区间0.45-0.69)和0.72(0.67-0.76)。为了提高准确性,我们测试了各种候选PCR截止值,显示0.08-0.10 g / g肌酐的PCR截止值可改善误分类率和kappa值。修改PCR临界值将提高其识别那些可从早期干预中受益的高风险人群的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号